6 insiders reported 24 Form 4 transactions for Oncocyte Corp (OCX) over the past 18 months (most recent 2025-02-11). Recent activity: James Andrea S. (Chief Financial Officer) Buy 97,561 shares, SMITH PATRICK W (Insider) Buy 1.1M shares, SMITH PATRICK W (Insider) Buy 385,814 shares, BROADWOOD PARTNERS, L.P. (Insider) Buy 660,207 shares, BROADWOOD CAPITAL INC (Insider) Buy 660,207 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-11 | James Andrea S. | Chief Financial Officer | Buy | 97,561 | $200,000 |
| 2025-02-11 | SMITH PATRICK W | Insider | Buy | 1.1M | $2.2M |
| 2025-02-11 | SMITH PATRICK W | Insider | Buy | 385,814 | $790,919 |
| 2025-02-10 | BROADWOOD PARTNERS, L.P. | Insider | Buy | 660,207 | $1.4M |
| 2025-02-10 | BROADWOOD CAPITAL INC | Insider | Buy | 660,207 | $1.4M |
| 2025-02-10 | BRADSHER NEAL C | Insider | Buy | 660,207 | $1.4M |
| 2025-02-10 | BROADWOOD PARTNERS, L.P. | Insider | Buy | 0 | $0 |
| 2025-02-10 | BROADWOOD CAPITAL INC | Insider | Buy | 0 | $0 |
| 2025-02-10 | BRADSHER NEAL C | Insider | Buy | 0 | $0 |
| 2025-02-10 | BROADWOOD PARTNERS, L.P. | Insider | Buy | 4.5M | $9.2M |
| 2025-02-10 | BROADWOOD CAPITAL INC | Insider | Buy | 4.5M | $9.2M |
| 2025-02-10 | BRADSHER NEAL C | Insider | Buy | 4.5M | $9.2M |
| 2025-02-10 | BROADWOOD PARTNERS, L.P. | Insider | Buy | 0 | $0 |
| 2025-02-10 | BROADWOOD CAPITAL INC | Insider | Buy | 0 | $0 |
| 2025-02-10 | BRADSHER NEAL C | Insider | Buy | 0 | $0 |
| 2025-02-04 | SMITH PATRICK W | Insider | Buy | 890 | $1,789 |
| 2025-02-04 | SMITH PATRICK W | Insider | Buy | 25 | $50 |
| 2025-01-31 | SMITH PATRICK W | Insider | Buy | 318 | $639 |
| 2025-01-31 | SMITH PATRICK W | Insider | Buy | 3,880 | $7,799 |
| 2025-01-15 | SMITH PATRICK W | Insider | Buy | 5,669 | $11,792 |
| 2025-01-15 | SMITH PATRICK W | Insider | Buy | 100 | $208 |
| 2025-01-15 | SMITH PATRICK W | Insider | Buy | 10,286 | $22,115 |
| 2024-12-27 | SMITH PATRICK W | Insider | Buy | 90,219 | $192,166 |
| 2024-12-26 | Arno Andrew | Director | Buy | 12,500 | $26,375 |
Source: SEC Form 4 filings · as of 2025-02-11